charles barkley glp-1 lost 50 pounds with GLP-1, stopped treatment, gained back 70 pounds, and now he's being paid millions to tell other men to take it. Let that sink in. He's a NBA Legend Charles Barkley Shows

These medications are part of a class called GLP-1 receptor agonists and were originally used to treat type 2 diabetes

Lilly is also advancing its oral GLP-1 candidate orforglipron, which recently reported strong Phase3 results, showing significant benefits for patients with obesity and type2 diabetes

This is particularly true if you live in the northern half of the US

The convergence of negotiated government pricing, the BALANCE Model, generic liraglutide availability, oral GLP-1 formulations, and next-generation agents like CagriSema and retatrutide suggests that coverage will continue expanding but with stronger cost management tools